Moderna made another big step forward in the fight against COVID-19 after the company reported incredibly positive data from the early-stage trial of its coronavirus vaccine.
Chris Lange Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus vaccine candidates received Fast Track Designation.
Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Apple, Disney, DuPont, Halliburton, Moderna, Phillips 66, Sunrun, Teladoc and more.
24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a big push as 2020 continues.
Monday's top analyst upgrades and downgrades included American Express, Boeing, Coca-Cola, Dunkin' Brands, L Brands, Lululemon Athletica, Moderna, NXP Semiconductors, Seagate Technology, ViacomCBS and Zillow.
Novavax shares jumped to start off the week after an update from its COVID-19 vaccine trial. This news adds to investor optimism and is helping to lift the broad markets in general.
Moderna made a big step towards a COVID-19 vaccine early on Monday, and investors (and the stock market in general) responded very positively.
Chris Lange Wednesday's top analyst upgrades and downgrades included Akamai Technologies, Carlyle, Ford, General Motors, JD.com, Moderna, Netflix, Peloton Interactive, Raytheon Technologies, Target, Tesla and Visa.
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting oversaturated?
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
24/7 Wall St. has tracked multiple S&P 500 and other large-cap stocks that actually closed up for the past week and that are also still higher year to date.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound…
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
In times like this, investors tend to move toward companies with rock-solid balance sheets and healthy dividends. These stocks were actually beating Monday’s sell-off and could offer long-term value for investors.
